Given the evidence of the health benefits of plant-based diets and long-chain n–3 (ω-3) fatty
acids, there is keen interest in better understanding the role of α-linolenic acid (ALA), a plant …

Twenty percent of deaths in the United States are secondary to cardiovascular diseases
(CVD). In patients with hyperlipidemia and hypertriglyceridemia, studies have shown high …

Objective To examine the associations between dietary intake and tissue biomarkers of
alpha linolenic acid (ALA) and risk of mortality from all causes, cardiovascular disease …

A healthy dietary pattern can benefit multiple cardiovascular disease (CVD) risk factors. In
conjunction with current standard-of-care pharmaceutical interventions it can provide an …

Cardiovascular diseases (CVDs) represent the leading cause of global mortality with 1.7
million deaths a year. One of the alternative systems to drug therapy to minimize the risk of …

Background The cardiovascular benefit from n‐3 polyunsaturated fatty acids (PUFAs) after
acute myocardial infarction (AMI) is controversial, and the importance of serum …

There is currently growing attention being paid to the role of elevated triglycerides (TGs) as
important mediators of residual atherosclerotic cardiovascular disease (ASCVD) risk. This …

Aims: Adequate intake of long-chain (LC) omega-3 polyunsaturated fatty acids (n-3 PUFAs)
is considered important for cardiovascular health. However, the effects of LC n-3 PUFAs on …

Low-density lipoprotein cholesterol (LDL-C) has been considered as the primary target for
the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However …

Precision cardiology aims to implement personalized health care and precise medical
decisions based on the specific characteristics of individuals. Metabolic remodeling plays a …